KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, +28

The Lancet

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematology +7

Erlotinib (Tarceva, OSI-774) Antagonizes ATP-Binding Cassette Subfamily B Member 1 and ATP-Binding Cassette Subfamily G Member 2–Mediated Drug Resistance

Zhi Shi, Xing-Xiang Peng, In‐Wha Kim, +9

Cancer Research

Drug TargetMolecular BiologyCancer BiologyTumor BiologyDrug Resistance +15

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

James R. Voelker, Paul H. Berg, Matthew J. Sheetz, +9

Journal of the American Society of Nephrology

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

Bijal Shah, Michael R. Bishop, Olalekan O. Oluwole, +24

Blood

Human Multidrug Resistance Protein 7 ( <i>ABCC10</i> ) Is a Resistance Factor for Nucleoside Analogues and Epothilone B

Elizabeth Hopper-Borge, Xiu Xu, Tong Shen, +3

Cancer Research

Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse

Xinchun Ye, Tong Shen, Jinxia Hu, +15

Experimental Neurology

ApoptosisCell DeathCerebral Vascular RegulationAutophagyBrain Injury +15

Statistical Damage Mechanics of Polymer Networks

Franck J. Vernerey, Roberto Brighenti, Rong Long, +1

Macromolecules

EngineeringMicromechanicsPolymer ChainsMechanical EngineeringProposed Micromechanical Model +17

Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance

Yehong Kuang, Tong Shen, Xiang Chen, +6

Biochemical Pharmacology

Molecular PharmacologyMedicinal ChemistryPotent Reversal AgentsDrug Resistance AnalysisMedicine +7

Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 study

John J.P. Kastelein, Steven E. Nissen, Daniel J. Rader, +4

European Heart Journal

Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance

Ying Zhou, Elizabeth Hopper-Borge, Tong Shen, +10

Biochemical Pharmacology

Molecular PharmacologyMedicinal ChemistryPotent Reversal AgentMedicinePharmacological Agent +5